General Information of the Drug (ID: M6APDG01233)
Name
2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole
Synonyms
2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole; SCHEMBL1407219; CHEMBL464189; BDBM26064; LGRUCHCYEMOENE-UHFFFAOYSA-N; 2-benzyl-3-aryl-7-trifluoromethylindazole, 5
    Click to Show/Hide
Status
Investigative
Structure
Formula
C21H15F3N2
InChI
1S/C21H15F3N2/c22-21(23,24)18-13-7-12-17-19(18)25-26(14-15-8-3-1-4-9-15)20(17)16-10-5-2-6-11-16/h1-13H,14H2
InChIKey
LGRUCHCYEMOENE-UHFFFAOYSA-N
PubChem CID
25137977
TTD Drug ID
D0Z8RH
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Oxysterols receptor LXR-alpha (NR1H3)
YTH domain-containing family protein 2 (YTHDF2)
In total 1 mechanisms lead to this potential drug response
Response Summary Oxysterols receptor LXR-alpha (NR1H3) is a therapeutic target for 2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole. The YTH domain-containing family protein 2 (YTHDF2) has potential in affecting the response of 2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole through regulating the expression of Oxysterols receptor LXR-alpha (NR1H3). [1], [2]
References
Ref 1 EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat Commun. 2021 Jan 8;12(1):177. doi: 10.1038/s41467-020-20379-7.
Ref 2 Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. J Nat Prod. 2005 Apr;68(4):617-9. doi: 10.1021/np050045j.